BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 33381913)

  • 21. Molecular alterations of the blood-brain barrier under inflammatory conditions: The role of endothelial to mesenchymal transition.
    Derada Troletti C; de Goede P; Kamermans A; de Vries HE
    Biochim Biophys Acta; 2016 Mar; 1862(3):452-60. PubMed ID: 26493443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of the mechanisms of blood-brain barrier disruption during COVID-19 infection.
    Jamil Al-Obaidi MM; Desa MNM
    J Neurosci Res; 2023 Nov; 101(11):1687-1698. PubMed ID: 37462109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of Vitis vinifera L. phenolic compounds on a blood-brain barrier culture model: Expression of leptin receptors and protection against cytokine-induced damage.
    Ardid-Ruiz A; Harazin A; Barna L; Walter FR; Bladé C; Suárez M; Deli MA; Aragonès G
    J Ethnopharmacol; 2020 Jan; 247():112253. PubMed ID: 31562952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. α1-Acid glycoprotein induced effects in rat brain microvessel endothelial cells.
    Zhang S; Mark KS
    Microvasc Res; 2012 Sep; 84(2):161-8. PubMed ID: 22633841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developmental regulation of barrier- and non-barrier blood vessels in the CNS.
    Ben-Zvi A; Liebner S
    J Intern Med; 2022 Jul; 292(1):31-46. PubMed ID: 33665890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cerebral endothelial cell as a key regulator of inflammatory processes in sterile inflammation.
    Ludewig P; Winneberger J; Magnus T
    J Neuroimmunol; 2019 Jan; 326():38-44. PubMed ID: 30472304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of restriction of viral neuroinvasion at the blood-brain barrier.
    Miner JJ; Diamond MS
    Curr Opin Immunol; 2016 Feb; 38():18-23. PubMed ID: 26590675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies.
    Huang J; Li YB; Charlebois C; Nguyen T; Liu Z; Bloemberg D; Zafer A; Baumann E; Sodja C; Leclerc S; Fewell G; Liu Q; Prabhakarpandian B; McComb S; Stanimirovic DB; Jezierski A
    Fluids Barriers CNS; 2022 Jun; 19(1):38. PubMed ID: 35650594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the blood-brain barrier in hypertension.
    Setiadi A; Korim WS; Elsaafien K; Yao ST
    Exp Physiol; 2018 Mar; 103(3):337-342. PubMed ID: 28986948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TREK-king the blood-brain-barrier.
    Bittner S; Ruck T; Fernández-Orth J; Meuth SG
    J Neuroimmune Pharmacol; 2014 Jun; 9(3):293-301. PubMed ID: 24557892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of Blood Brain Barrier Disruption by Different Types of Bacteria, and Bacterial-Host Interactions Facilitate the Bacterial Pathogen Invading the Brain.
    Al-Obaidi MMJ; Desa MNM
    Cell Mol Neurobiol; 2018 Oct; 38(7):1349-1368. PubMed ID: 30117097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosine receptor signaling: a key to opening the blood-brain door.
    Bynoe MS; Viret C; Yan A; Kim DG
    Fluids Barriers CNS; 2015 Sep; 12():20. PubMed ID: 26330053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caspase-1 has a critical role in blood-brain barrier injury and its inhibition contributes to multifaceted repair.
    Israelov H; Ravid O; Atrakchi D; Rand D; Elhaik S; Bresler Y; Twitto-Greenberg R; Omesi L; Liraz-Zaltsman S; Gosselet F; Schnaider Beeri M; Cooper I
    J Neuroinflammation; 2020 Sep; 17(1):267. PubMed ID: 32907600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon in the CNS.
    Bhat H; Lang KS; Hardt C; Lang J
    Neurosignals; 2019; 27(S1):44-53. PubMed ID: 31865647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How do immune cells overcome the blood-brain barrier in multiple sclerosis?
    Larochelle C; Alvarez JI; Prat A
    FEBS Lett; 2011 Dec; 585(23):3770-80. PubMed ID: 21550344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular mechanisms of IL-17-induced blood-brain barrier disruption.
    Huppert J; Closhen D; Croxford A; White R; Kulig P; Pietrowski E; Bechmann I; Becher B; Luhmann HJ; Waisman A; Kuhlmann CR
    FASEB J; 2010 Apr; 24(4):1023-34. PubMed ID: 19940258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the Cannabinoid CB
    Kho DT; Glass M; Graham ES
    Adv Pharmacol; 2017; 80():367-396. PubMed ID: 28826541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia?
    Feng S; Huang Y; Chen Z
    Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What we know: the inflammatory basis of hepatic encephalopathy.
    Milewski K; Oria M
    Metab Brain Dis; 2016 Dec; 31(6):1239-1247. PubMed ID: 26497651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glial influences on BBB functions and molecular players in immune cell trafficking.
    Lécuyer MA; Kebir H; Prat A
    Biochim Biophys Acta; 2016 Mar; 1862(3):472-82. PubMed ID: 26454208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.